Grade @ or @ adverse events of hypertension ( @ % ) , neutropenia ( @ % ) , liver-related toxicity ( @ % ) , diarrhea ( @ % ) , fatigue ( @ % ) , thrombocytopenia ( @ % ) , and palmar-plantar erythrodysesthesia ( @ % ) were significantly higher in the pazopanib arm .